Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gaetano De Santis"'
Autor:
Rosanna Maria Miccolis, Gaetano De Santis, Caterina Buquicchio, Teresa Maria Santeramo, Mariangela Leo, Candida Rosaria Germano, Giovanna Lerario, Vera Carluccio, Sonia Mallano, Lina Cardisciani, Luisa Di Sciascio, Giuseppe Tarantini
Publikováno v:
BioMed, Vol 3, Iss 1, Pp 50-58 (2023)
Intravascular large B-cell Lymphoma (IVLBCL) is a rare subtype of extranodal non-Hodgkin’s lymphoma that is challenging to diagnose and has a poor prognosis. Here, we describe two patients newly diagnosed with IVLBCL at our institution: an African
Externí odkaz:
https://doaj.org/article/c95a3f466151490f837b39c6dcd3ef0a
Autor:
Francesco Gaudio, Giacomo Loseto, Valentina Bozzoli, Potito Rosario Scalzulli, Anna Maria Mazzone, Lorenzo Tonialini, Vincenza Fesce, Giovanni Quintana, Gaetano De Santis, Pierluigi Masciopinto, Elena Arcuti, Felice Clemente, Stefania Scardino, Giuseppe Tarantini, Domenico Pastore, Lorella Melillo, Vincenzo Pavone, Alessandro Maggi, Angelo Michele Carella, Nicola Di Renzo, Attilio Guarini, Pellegrino Musto
Publikováno v:
Annals of Hematology. 102:385-392
Autor:
Alessandro Isidori, Federica Loscocco, Giuseppe Visani, Sara Paolasini, Potito Scalzulli, Pellegrino Musto, Tommasina Perrone, Attilio Guarini, Domenico Pastore, Patrizio Mazza, Lorenzo Tonialini, Vincenzo Pavone, Gaetano De Santis, Giuseppe Tarantini
Publikováno v:
British journal of haematologyREFERENCES. 199(3)
Idelalisib, a reversible inhibitor of PI3Kδ (phosphoinositide-3 kinase delta), showed remarkable activity in the phase II DELTA trial, leading to its approval by the European Medicines Agency (EMA) in patients with relapsed/refractory (R/R) follicul
Autor:
Nicola Cascavilla, Felicina Li Gioi, Giuseppina Ricciuti, Maurizio Musso, Alessandra Crescimanno, Ferdinando Porretto, Gaetano De Santis, Emilio Iannitto, Annalisa Chiarenza, Ugo Consoli, Attilio Guarini, Maria Cristina Pirosa, Antonino Greco, Giuseppe Tarantini, Marilena Salerno, Saverio Mantuano, Carla Minoia, Donato Mannina, Francesco Di Raimondo, Alessandra Romano, Potito Rosario Scalzulli, Enzo Pavone, Renato Scalone, Anastasia Laura Caruso, Vincenza Bonanno
Publikováno v:
European journal of haematologyREFERENCES. 104(6)
Objective and methods In order to assess the efficacy of brentuximab vedotin (Bv) in combination with bendamustine (B) in multiple relapsed or refractory (RR) classic Hodgkin lymphoma (cHL), medical records of 47 patients treated with BvB in second r
Autor:
Nicola Cascavilla, Potito Rosario Scalzulli, Domenico Pastore, Antonino Greco, Gaetano De Santis, Attilio Guarini, Giuseppe Tarantini, Nicola Di Renzo, Alessandro Maggi, Giacomo Loseto, Maria Rosa Valvano, Anna Maria Giordano, Giorgina Specchia, Patrizio Mazza, Maria Rosaria De Paolis, Vincenzo Pavone, Giovanni Quintana
Publikováno v:
Blood. 132:5557-5557
Background: Ibrutinib is a first-in-class oral inhibitor of Bruton Tyrosine Kinase (BTK) approved for the treatment patients with CLL who have received at least one prior therapy (R/R) or Treatment Naïve (TN) with del17p. Ibrutinib has been showed t
Autor:
Cosima Battista, Michela Dargenio, Mario Delia, Angela Ciancio, Daniela Diomede, Gaetano De Santis, Silvana Capalbo, Vincenzo Liso
Publikováno v:
Acta haematologica. 108(2)
Serum levels of tumor necrosis factor-alpha (TNF-alpha) and of erythropoietin (Epo) have been evaluated in 100 patients with B-cell chronic lymphocytic leukemia (CLL) in order to determine whether these factors could be significant in the development